Toll Free: 1-888-928-9744

IMPACT Therapeutics, Inc. - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 35 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

IMPACT Therapeutics, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'IMPACT Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the IMPACT Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of IMPACT Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of IMPACT Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of IMPACT Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the IMPACT Therapeutics, Inc.'s pipeline products

Reasons to buy

- Evaluate IMPACT Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of IMPACT Therapeutics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the IMPACT Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of IMPACT Therapeutics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of IMPACT Therapeutics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of IMPACT Therapeutics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
IMPACT Therapeutics, Inc. Snapshot 5
IMPACT Therapeutics, Inc. Overview 5
Key Information 5
Key Facts 5
IMPACT Therapeutics, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
IMPACT Therapeutics, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
IMPACT Therapeutics, Inc. - Pipeline Products Glance 11
IMPACT Therapeutics, Inc. - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
IMPACT Therapeutics, Inc. - Drug Profiles 13
IMP-03138 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
IMP-04149 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
IMP-04297 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
IMP-05364 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
IMP-05403 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Small Molecules to Inhibit Hedgehog Pathway for Oncology 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
IMP-04100 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
IMP-04111 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
IMP-04249 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
IMP-04307 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
IMP-04356 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
IMP-05361 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
IMP-05367 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
IMP-05369 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
IMP-05379 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
IMPACT Therapeutics, Inc. - Pipeline Analysis 28
IMPACT Therapeutics, Inc. - Pipeline Products by Target 28
IMPACT Therapeutics, Inc. - Pipeline Products by Route of Administration 29
IMPACT Therapeutics, Inc. - Pipeline Products by Molecule Type 30
IMPACT Therapeutics, Inc. - Pipeline Products by Mechanism of Action 31
IMPACT Therapeutics, Inc. - Dormant Projects 32
IMPACT Therapeutics, Inc. - Locations And Subsidiaries 33
Head Office 33
Appendix 34
Methodology 34
Coverage 34
Secondary Research 34
Primary Research 34
Expert Panel Validation 34
Contact Us 35
Disclaimer 35
List of Tables
IMPACT Therapeutics, Inc., Key Information 5
IMPACT Therapeutics, Inc., Key Facts 5
IMPACT Therapeutics, Inc. - Pipeline by Indication, 2014 8
IMPACT Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9
IMPACT Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10
IMPACT Therapeutics, Inc. - Preclinical, 2014 11
IMPACT Therapeutics, Inc. - Discovery, 2014 12
IMPACT Therapeutics, Inc. - Pipeline by Target, 2014 28
IMPACT Therapeutics, Inc. - Pipeline by Route of Administration, 2014 29
IMPACT Therapeutics, Inc. - Pipeline by Molecule Type, 2014 30
IMPACT Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 31
IMPACT Therapeutics, Inc. - Dormant Developmental Projects,2014 32 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify